Sumner H Cathcart

Title: Sumner H. Cathcart: Innovator in Pharmaceutical Technology

Introduction

Sumner H. Cathcart is a notable inventor based in Mattawan, MI (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of drug release formulations. His innovative approach has led to advancements that benefit both manufacturers and patients.

Latest Patents

Sumner H. Cathcart holds a patent for "Tablets exhibiting reduced drug release variability." This invention describes a compressible extended release tablet or tablet layer that has a drug release profile that is not strongly dependent on tablet hardness. The formulation is prepared by dry blending a pharmaceutically active ingredient with hydroxypropyl methylcellulose. Notably, the hydroxypropyl methylcellulose used has a bimodal or multimodal number average molecular weight distribution, which includes at least one mode over 20,000 Daltons and at least one mode under 10,000 Daltons. An additional advantage of this invention is that the tablet formulations can be prepared without the need for wet granulation.

Career Highlights

Sumner is associated with L. Perrigo Company, where he has been able to apply his expertise in pharmaceutical formulations. His work has contributed to the company's reputation for quality and innovation in the healthcare sector.

Collaborations

Throughout his career, Sumner has collaborated with talented individuals such as Jaber G. Qasem and Jack T. Irwin. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Sumner H. Cathcart's contributions to pharmaceutical technology exemplify the impact of innovative thinking in the industry. His patent for tablets with reduced drug release variability showcases his commitment to improving drug formulations. His work continues to influence the field and enhance patient care.